```html

Nicotinic (Tobacco) Poisoning – Comprehensive Medical Guide

Overview

Nicotinic poisoning, often called tobacco poisoning, occurs when a person is exposed to a toxic dose of nicotine. Nicotine is a naturally occurring alkaloid found in the leaves of the tobacco plant (Nicotiana tabacum). While low doses act as a stimulant, high concentrations overwhelm the body’s cholinergic system, producing a rapid onset of systemic toxicity.

• Who it affects: Anyone can be poisoned, but children (especially <5 years old), accidental ingesters (e.g., chewing nicotine gum or e‑liquid), and people handling raw tobacco or concentrated nicotine solutions (e.g., e‑cigarette manufacturers, hobbyists) are at greatest risk.
• Prevalence: In the United States, >2,500 nicotine exposure calls to poison control centers were reported in 2022, with ~10 % involving severe outcomes (CDC). Worldwide, the rise of high‑strength nicotine e‑liquids (>50 mg/mL) has increased accidental exposures, especially among adolescents (WHO).

Symptoms

Nicotine acts on both nicotinic acetylcholine receptors (nAChR) in the autonomic and somatic nervous systems. Early symptoms reflect an initial “stimulatory” phase, followed by a “depressant” phase as receptors become desensitized. The timeframe is usually seconds to minutes after exposure.

Early (Stimulatory) Phase – 0–30 minutes

• Gastrointestinal: Nausea, vomiting, abdominal cramps, diarrhea.
• Neurologic: Dizziness, headache, agitation, tremor, seizures (rare but possible).
• Cardiovascular: Tachycardia, hypertension, palpitations.
• Respiratory: Dyspnea, bronchorrhea (excessive secretions).
• Salivation & Lacrimation: Excessive drooling and tearing.

Late (Depressant) Phase – 30 minutes to several hours

• Cardiovascular: Bradycardia, hypotension, arrhythmias (including ventricular tachycardia).
• Neurologic: Confusion, stupor, coma, seizures (may recur).
• Respiratory: Respiratory depression, apnea, bronchospasm.
• Muscular: Weakness, fasciculations, paralysis.
• Dermatologic: Flushing, pallor, diaphoresis.

Rare but Critical Signs

• Sudden cardiac arrest
• Severe metabolic acidosis
• Rhabdomyolysis (muscle breakdown)

Causes and Risk Factors

Nicotine poisoning can be acute (single large exposure) or chronic (repeated high‑dose exposure). The most common routes are ingestion, dermal absorption, and inhalation.

Common Sources

• Oral ingestion: Swallowing loose tobacco, nicotine gum/lozenges, or e‑liquid from vaping devices.
• Dermal contact: Handling nicotine concentrate without gloves; nicotine patches applied improperly.
• Inhalation: Vaping high‑strength liquids, accidental spray from nicotine‑filled containers.
• Intravenous/Intranasal: Rare, usually related to intentional self‑harm.

Risk Factors

• Young children – curiosity and hand‑to‑mouth behavior.
• Occupational exposure – e‑cigarette manufacturers, agricultural workers handling tobacco leaves.
• Improper storage of nicotine solutions (e.g., in candy‑sized bottles).
• Use of high‑strength nicotine products (>50 mg/mL) without proper education.
• Pre‑existing cardiovascular disease, which can exacerbate nicotinic‑induced arrhythmias.

Diagnosis

Diagnosis is primarily clinical, supported by a focused history and targeted laboratory testing.

Clinical Assessment

• Obtain a detailed exposure history: product type, concentration, amount, route, time since exposure.
• Physical exam focusing on vital signs, level of consciousness, skin signs (sweating, flushing), and cardiac rhythm.

Laboratory Tests

• Serum nicotine level: Not routinely available in most EDs; useful for medico‑legal cases.
• Blood gas analysis: Detects respiratory depression or metabolic acidosis.
• Electrolytes & glucose: Assess for secondary disturbances.
• Cardiac monitoring: Continuous ECG to identify arrhythmias.
• Creatine kinase (CK) and urine myoglobin: Screen for rhabdomyolysis.

Imaging (if indicated)

• Chest X‑ray for aspiration pneumonia.
• CT head if seizures or focal neurologic deficits develop.

Treatment Options

Management is supportive and aimed at preventing absorption, counteracting toxicity, and stabilizing vital functions.

Initial Stabilization (ABCs)

• Airway: Secure with endotracheal intubation if altered mental status or respiratory compromise.
• Breathing: Provide supplemental O₂, consider mechanical ventilation for severe depression.
• Circulation: IV access, cardiac monitoring, treat hypotension with isotonic fluids; vasopressors (e.g., norepinephrine) if refractory.

Decontamination

• Gastric lavage: Within 1 hour of ingestion and if airway protected.
• Activated charcoal: 1 g/kg (max 50 g) orally to bind nicotine; repeat dose if delayed gastric emptying.
• Dermal decontamination: Immediate removal of contaminated clothing; wash skin thoroughly with soap and water.

Pharmacologic Therapy

• Atropine: 0.5–2 mg IV bolus for severe bradycardia or bronchospasm; repeat every 5 minutes as needed.
• Benzodiazepines: Lorazepam 0.1 mg/kg IV for seizures or severe agitation.
• Beta‑blockers: Generally avoided because they may exacerbate bronchospasm; use only under specialist guidance.
• IV lipid emulsion (ILE): Considered for refractory cardiovascular collapse; dosing per 2015 ASRA guidelines (1.5 mL/kg 20 % lipid bolus, then infusion).

Supportive Measures

• Continuous cardiac rhythm monitoring for at least 24 hours.
• Fluid resuscitation to maintain renal perfusion; monitor urine output.
• Correct electrolyte abnormalities—especially potassium and calcium.
• Consult toxicology or poison‑control center early (US CDC: Poison.org).

Disposition

• Mild cases (e.g., small ingestion, stable vitals): observation for 4–6 hours, then discharge with instructions.
• Moderate to severe cases: admission to ICU, serial labs, and cardiac monitoring.

Living with Nicotinic Poisoning (Tobacco Poisoning)

Even after an acute event, patients may need ongoing care, especially if they have a nicotine use disorder.

• Medication review: Avoid over‑the‑counter nicotine replacement therapy (NRT) unless prescribed.
• Follow‑up: Schedule an appointment with primary care or a toxicology specialist within 1 week.
• Neurologic monitoring: Report persistent headaches, memory problems, or mood changes.
• Cardiovascular health: Obtain a baseline ECG; repeat if palpitations recur.
• Psychosocial support: Referral to counseling or cessation programs (e.g., quitlines, behavioral therapy) if nicotine dependence is present.
• Safety at home: Store all nicotine products (including e‑liquids, patches, gum) out of reach of children—preferably locked cabinets.

Prevention

Preventing nicotine poisoning relies on education, safe storage, and regulatory measures.

For Households

• Keep nicotine products in child‑proof containers and high shelves.
• Never store nicotine liquids in candy‑sized bottles; label all containers clearly.
• Dispose of empty nicotine containers promptly.
• Use gloves when handling nicotine concentrates.

For Workers

• Follow OSHA (or local) guidelines for personal protective equipment (PPE) when manufacturing e‑liquids.
• Implement spill‑control protocols and regular air monitoring.

Public Health Strategies

• Regulatory limits on nicotine concentration in consumer e‑liquids (e.g., EU Tobacco Products Directive caps at 20 mg/mL).
• Mandatory child‑resistant packaging for nicotine gum, patches, and liquids.
• Education campaigns targeting parents and adolescents about the dangers of accidental ingestion.

Complications

If not recognized promptly, nicotine poisoning can lead to serious, sometimes permanent, sequelae.

• Cardiac: Persistent arrhythmias, myocardial infarction, or sudden cardiac death.
• Neurologic: Anoxic brain injury from prolonged hypoxia, seizures, or status epilepticus.
• Respiratory: Acute respiratory distress syndrome (ARDS) secondary to aspiration or pulmonary edema.
• Renal: Acute kidney injury from rhabdomyolysis.
• Psychiatric: Development or worsening of nicotine dependence, anxiety, or depression after a traumatic exposure.
• Chronic exposure effects: Hypertension, endothelial dysfunction, and increased risk of atherosclerotic disease (observed in heavy occupational exposure cohorts).

When to Seek Emergency Care

---

Sources: Mayo Clinic, CDC Poison Control, WHO Tobacco Fact Sheet 2023, Cleveland Clinic, National Institute on Drug Abuse (NIDA), American Society of Regional Anesthesia (ASRA) lipid emulsion guidelines, peer‑reviewed toxicology journals (e.g., Toxicology Communications, 2022).

```